On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Astellas Pharma Europe BV's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€275k · 4 projects
- Horizon 2020€0 · 9 projects
- Horizon Europe€0 · 1 project
Projects
14 EU-funded projects, newest first. Each links to the official record.
- BRIDGEPartner
Breakthrough Regulatory Innovation and Development throuGh sandbox Environments
Horizon Europe · 2025–2028 · Project on CORDIS ↗
- BEAMERPartner
BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe
Horizon 2020 · 2021–2027 · Project on CORDIS ↗
- T2EVOLVEPartner
Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
- ARDATPartner
Accelerating Research & Development for Advanced Therapies
Horizon 2020 · 2020–2026 · Project on CORDIS ↗
- MELLODDYPartner
MachinE Learning Ledger Orchestration for Drug DiscoverY
Horizon 2020 · 2019–2022 · Project on CORDIS ↗
- PIONEERPartner
Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope
Horizon 2020 · 2018–2023 · Project on CORDIS ↗
- PREFERPartner
Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966
Horizon 2020 · 2016–2022 · Project on CORDIS ↗
- BEAt-DKDPartner
Biomarker Enterprise to Attack DKD - Sofia ref.: 115974
Horizon 2020 · 2016–2023 · Project on CORDIS ↗
- SPRINTTPartner
Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies
FP7 (2007 to 2013) · 2014–2020 · Project on CORDIS ↗
- TRUSTPartner
Training Urology Scientists to develop Treatments
FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗
€239ktheir share - FLIPPartner
Fatty liver: Inhibition of Progression
FP7 (2007 to 2013) · 2010–2013 · Project on CORDIS ↗
€36ktheir share - EUROPAINPartner
Understanding chronic pain and improving its treatment
FP7 (2007 to 2013) · 2009–2015 · Project on CORDIS ↗
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Janssen Pharmaceutica NVBelgium · 8 shared projects
- Bayer AktiengesellschaftGermany · 8 shared projects
- Sanofi-Aventis Recherche & DeveloppementFrance · 7 shared projects
- Takeda Pharmaceuticals International AGSwitzerland · 7 shared projects
- Novartis Pharma AGSwitzerland · 6 shared projects
- Eli Lilly and Company LtdUnited Kingdom · 6 shared projects
- Astrazeneca ABSweden · 5 shared projects
- Merck Kommanditgesellschaft Auf AktienGermany · 5 shared projects
- Boehringer Ingelheim InternationalgmbhGermany · 5 shared projects
- Pfizer LimitedUnited Kingdom · 5 shared projects
- Katholieke Universiteit LeuvenBelgium · 4 shared projects
- Novo Nordisk A/SDenmark · 4 shared projects
- Glaxosmithkline Research & Development LimitedUnited Kingdom · 4 shared projects
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 3 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 3 shared projects
- University College LondonUnited Kingdom · 3 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- DNA
- anatomy and morphology
- artificial intelligence
- business models
- cells technologies
- coronaviruses
- databases
- diabetes
- drug discovery
- drug safety
- gene therapy
- genomes
- health care services
- hepatology
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
